Healthcare -
Biotechnology - NASDAQ - US
$ 26.5
0.607 %
$ 2.22 B
Market Cap
-5.79
P/E
Price Target
Average
90.57%
Revenue Forecast
Estimate
--16.06%
EBIT
Estimate
--4.18%
Net Income
Estimate
--23.88%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Beam Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for BEAM of $50.5 , with forecasts ranging from
a
low of
$37 to a high of $69 .
BEAM Lowest Price Target
Wall Street Target
37 USD
39.62%
BEAM Average Price Target
Wall Street Target
50.5 USD
90.57%
BEAM Highest Price Target
Wall Street Target
69 USD
160.38%
REVENUE FORECAST
Revenue Forecast Chart BEAM
EBIT FORECAST
EBIT Forecast Chart BEAM
NET INCOME FORECAST
Net Income Chart BEAM